Structure

Physi-Chem Properties

Molecular Weight:  702.25
Volume:  658.862
LogP:  2.208
LogD:  1.664
LogS:  -5.044
# Rotatable Bonds:  11
TPSA:  181.56
# H-Bond Aceptor:  15
# H-Bond Donor:  0
# Rings:  8
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.299
Synthetic Accessibility Score:  7.748
Fsp3:  0.743
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.357
MDCK Permeability:  0.00010510655556572601
Pgp-inhibitor:  0.999
Pgp-substrate:  0.71
Human Intestinal Absorption (HIA):  0.103
20% Bioavailability (F20%):  0.744
30% Bioavailability (F30%):  0.161

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.522
Plasma Protein Binding (PPB):  59.636199951171875%
Volume Distribution (VD):  1.295
Pgp-substrate:  26.789899826049805%

ADMET: Metabolism

CYP1A2-inhibitor:  0.001
CYP1A2-substrate:  0.942
CYP2C19-inhibitor:  0.064
CYP2C19-substrate:  0.111
CYP2C9-inhibitor:  0.076
CYP2C9-substrate:  0.001
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.047
CYP3A4-inhibitor:  0.818
CYP3A4-substrate:  0.883

ADMET: Excretion

Clearance (CL):  1.29
Half-life (T1/2):  0.284

ADMET: Toxicity

hERG Blockers:  0.074
Human Hepatotoxicity (H-HT):  0.959
Drug-inuced Liver Injury (DILI):  0.958
AMES Toxicity:  0.991
Rat Oral Acute Toxicity:  0.999
Maximum Recommended Daily Dose:  0.961
Skin Sensitization:  0.576
Carcinogencity:  0.869
Eye Corrosion:  0.003
Eye Irritation:  0.067
Respiratory Toxicity:  0.962

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470181

Natural Product ID:  NPC470181
Common Name*:   Xyloccensin E
IUPAC Name:   n.a.
Synonyms:   Xyloccensin E
Standard InCHIKey:  HBXWLQXJFYLQHO-OPSRHREQSA-N
Standard InCHI:  InChI=1S/C35H42O15/c1-17(36)43-26-29(5)16-33-30(6,25(29)46-23(40)15-41-8)32-11-10-28(4)21(13-22(39)45-24(28)20-9-12-42-14-20)34(32,50-31(7,48-32)49-33)27(44-18(2)37)35(26,33)47-19(3)38/h9,12,14,21,24-27H,10-11,13,15-16H2,1-8H3/t21-,24+,25+,26+,27-,28-,29-,30-,31+,32+,33-,34-,35+/m1/s1
SMILES:  CC(=O)OC1C2(CC34C1(C(C56C7CC(=O)OC(C7(CCC5(C3(C2OC(=O)COC)C)OC(O4)(O6)C)C)C8=COC=C8)OC(=O)C)OC(=O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1808138
PubChem CID:   56680327
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0001538] Diterpene lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[20112995]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[20146503]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds Thai n.a. PMID[21733687]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[22724531]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[26114936]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 > 27000.0 nM PMID[525728]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470181 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9755 High Similarity NPC477824
0.9273 High Similarity NPC327922
0.9176 High Similarity NPC470938
0.8941 High Similarity NPC236004
0.8941 High Similarity NPC94763
0.8802 High Similarity NPC472139
0.878 High Similarity NPC476262
0.8757 High Similarity NPC476224
0.8728 High Similarity NPC478177
0.8698 High Similarity NPC478178
0.8693 High Similarity NPC242068
0.8693 High Similarity NPC247563
0.8693 High Similarity NPC105395
0.869 High Similarity NPC469846
0.8671 High Similarity NPC469633
0.8663 High Similarity NPC469848
0.8659 High Similarity NPC476201
0.8613 High Similarity NPC469576
0.8605 High Similarity NPC159232
0.858 High Similarity NPC165218
0.858 High Similarity NPC472669
0.8547 High Similarity NPC82602
0.8537 High Similarity NPC476122
0.8521 High Similarity NPC471166
0.8521 High Similarity NPC471167
0.8521 High Similarity NPC6326
0.8521 High Similarity NPC82851
0.8521 High Similarity NPC117986
0.8521 High Similarity NPC472668
0.8512 High Similarity NPC475295
0.8512 High Similarity NPC473473
0.8506 High Similarity NPC471437
0.8497 Intermediate Similarity NPC160818
0.8497 Intermediate Similarity NPC285227
0.8497 Intermediate Similarity NPC169299
0.8488 Intermediate Similarity NPC242334
0.848 Intermediate Similarity NPC97574
0.848 Intermediate Similarity NPC472141
0.848 Intermediate Similarity NPC93172
0.8471 Intermediate Similarity NPC471168
0.8462 Intermediate Similarity NPC472653
0.8452 Intermediate Similarity NPC472283
0.8452 Intermediate Similarity NPC286722
0.8439 Intermediate Similarity NPC472650
0.8434 Intermediate Similarity NPC84063
0.843 Intermediate Similarity NPC478179
0.8421 Intermediate Similarity NPC470182
0.8412 Intermediate Similarity NPC200782
0.8412 Intermediate Similarity NPC470939
0.8412 Intermediate Similarity NPC96443
0.8412 Intermediate Similarity NPC290400
0.8393 Intermediate Similarity NPC126723
0.8393 Intermediate Similarity NPC471169
0.8393 Intermediate Similarity NPC175964
0.8393 Intermediate Similarity NPC107646
0.8393 Intermediate Similarity NPC209364
0.8382 Intermediate Similarity NPC271235
0.8372 Intermediate Similarity NPC214600
0.8363 Intermediate Similarity NPC39986
0.8363 Intermediate Similarity NPC134254
0.8363 Intermediate Similarity NPC302369
0.8353 Intermediate Similarity NPC475381
0.8353 Intermediate Similarity NPC191828
0.8353 Intermediate Similarity NPC305016
0.8352 Intermediate Similarity NPC262386
0.8343 Intermediate Similarity NPC167142
0.8343 Intermediate Similarity NPC249021
0.8343 Intermediate Similarity NPC195131
0.8333 Intermediate Similarity NPC472659
0.8333 Intermediate Similarity NPC471175
0.8324 Intermediate Similarity NPC472764
0.8323 Intermediate Similarity NPC322546
0.8323 Intermediate Similarity NPC308205
0.8314 Intermediate Similarity NPC271657
0.8314 Intermediate Similarity NPC469849
0.8314 Intermediate Similarity NPC259943
0.8304 Intermediate Similarity NPC197596
0.8304 Intermediate Similarity NPC18347
0.8304 Intermediate Similarity NPC149896
0.8294 Intermediate Similarity NPC475967
0.8294 Intermediate Similarity NPC474932
0.8294 Intermediate Similarity NPC475226
0.8284 Intermediate Similarity NPC204663
0.8276 Intermediate Similarity NPC472765
0.8276 Intermediate Similarity NPC472652
0.8276 Intermediate Similarity NPC472766
0.8276 Intermediate Similarity NPC160651
0.8276 Intermediate Similarity NPC472673
0.8274 Intermediate Similarity NPC282445
0.8266 Intermediate Similarity NPC149945
0.8266 Intermediate Similarity NPC470875
0.8263 Intermediate Similarity NPC18135
0.8256 Intermediate Similarity NPC419
0.8256 Intermediate Similarity NPC234660
0.8256 Intermediate Similarity NPC469338
0.8256 Intermediate Similarity NPC51568
0.8256 Intermediate Similarity NPC292389
0.8256 Intermediate Similarity NPC477405
0.8256 Intermediate Similarity NPC476197
0.8246 Intermediate Similarity NPC335761
0.8218 Intermediate Similarity NPC476861
0.8218 Intermediate Similarity NPC472775
0.8218 Intermediate Similarity NPC100333
0.8218 Intermediate Similarity NPC472774
0.8218 Intermediate Similarity NPC472651
0.8218 Intermediate Similarity NPC173516
0.8218 Intermediate Similarity NPC476850
0.8214 Intermediate Similarity NPC29695
0.8214 Intermediate Similarity NPC182427
0.8208 Intermediate Similarity NPC470940
0.8208 Intermediate Similarity NPC476857
0.8208 Intermediate Similarity NPC476856
0.8208 Intermediate Similarity NPC276551
0.8208 Intermediate Similarity NPC476858
0.8204 Intermediate Similarity NPC477404
0.8204 Intermediate Similarity NPC196864
0.8198 Intermediate Similarity NPC211777
0.8198 Intermediate Similarity NPC5079
0.8198 Intermediate Similarity NPC207978
0.8192 Intermediate Similarity NPC471632
0.8187 Intermediate Similarity NPC237155
0.8187 Intermediate Similarity NPC307383
0.8176 Intermediate Similarity NPC60973
0.8171 Intermediate Similarity NPC471397
0.815 Intermediate Similarity NPC198047
0.8144 Intermediate Similarity NPC470791
0.8144 Intermediate Similarity NPC470790
0.814 Intermediate Similarity NPC25255
0.814 Intermediate Similarity NPC470789
0.8133 Intermediate Similarity NPC470941
0.8129 Intermediate Similarity NPC299038
0.8129 Intermediate Similarity NPC261597
0.8129 Intermediate Similarity NPC36655
0.8129 Intermediate Similarity NPC45101
0.8129 Intermediate Similarity NPC470119
0.8129 Intermediate Similarity NPC469847
0.8129 Intermediate Similarity NPC214495
0.8125 Intermediate Similarity NPC470995
0.8118 Intermediate Similarity NPC469850
0.8118 Intermediate Similarity NPC44675
0.8118 Intermediate Similarity NPC214541
0.8114 Intermediate Similarity NPC472282
0.8114 Intermediate Similarity NPC476853
0.8114 Intermediate Similarity NPC473766
0.8114 Intermediate Similarity NPC473753
0.8107 Intermediate Similarity NPC469503
0.8103 Intermediate Similarity NPC123088
0.8103 Intermediate Similarity NPC476860
0.8095 Intermediate Similarity NPC469335
0.8095 Intermediate Similarity NPC159927
0.8095 Intermediate Similarity NPC156189
0.8092 Intermediate Similarity NPC5741
0.8092 Intermediate Similarity NPC470792
0.8092 Intermediate Similarity NPC329938
0.8092 Intermediate Similarity NPC69028
0.8092 Intermediate Similarity NPC472767
0.8092 Intermediate Similarity NPC472771
0.8092 Intermediate Similarity NPC193798
0.8081 Intermediate Similarity NPC477403
0.807 Intermediate Similarity NPC263265
0.8057 Intermediate Similarity NPC472670
0.8057 Intermediate Similarity NPC23387
0.8057 Intermediate Similarity NPC307781
0.8047 Intermediate Similarity NPC471000
0.8046 Intermediate Similarity NPC224394
0.8046 Intermediate Similarity NPC472773
0.8046 Intermediate Similarity NPC663
0.8045 Intermediate Similarity NPC167340
0.8036 Intermediate Similarity NPC471001
0.8024 Intermediate Similarity NPC255414
0.8024 Intermediate Similarity NPC221809
0.8023 Intermediate Similarity NPC187149
0.8023 Intermediate Similarity NPC475066
0.8023 Intermediate Similarity NPC302392
0.8 Intermediate Similarity NPC61967
0.8 Intermediate Similarity NPC146991
0.8 Intermediate Similarity NPC472672
0.7989 Intermediate Similarity NPC263432
0.7988 Intermediate Similarity NPC46551
0.7978 Intermediate Similarity NPC475641
0.7978 Intermediate Similarity NPC186746
0.7978 Intermediate Similarity NPC475237
0.7977 Intermediate Similarity NPC472671
0.7977 Intermediate Similarity NPC262872
0.7964 Intermediate Similarity NPC262198
0.7953 Intermediate Similarity NPC30222
0.7953 Intermediate Similarity NPC253201
0.7953 Intermediate Similarity NPC302054
0.7943 Intermediate Similarity NPC476035
0.7943 Intermediate Similarity NPC475039
0.7943 Intermediate Similarity NPC14499
0.7941 Intermediate Similarity NPC116717
0.7931 Intermediate Similarity NPC477402
0.7929 Intermediate Similarity NPC472654
0.7929 Intermediate Similarity NPC125182
0.7929 Intermediate Similarity NPC69647
0.7921 Intermediate Similarity NPC88593
0.7919 Intermediate Similarity NPC472778
0.7919 Intermediate Similarity NPC472772
0.7919 Intermediate Similarity NPC470118

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470181 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8118 Intermediate Similarity NPD5761 Phase 2
0.8118 Intermediate Similarity NPD5760 Phase 2
0.7634 Intermediate Similarity NPD8434 Phase 2
0.7627 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7366 Intermediate Similarity NPD6764 Approved
0.7366 Intermediate Similarity NPD6765 Approved
0.7337 Intermediate Similarity NPD7799 Discontinued
0.7211 Intermediate Similarity NPD6784 Approved
0.7211 Intermediate Similarity NPD6785 Approved
0.7113 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7104 Intermediate Similarity NPD5494 Approved
0.709 Intermediate Similarity NPD7685 Pre-registration
0.6931 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6923 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6902 Remote Similarity NPD7075 Discontinued
0.6898 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6857 Remote Similarity NPD8404 Phase 2
0.6851 Remote Similarity NPD6599 Discontinued
0.6847 Remote Similarity NPD7497 Discontinued
0.6831 Remote Similarity NPD7819 Suspended
0.6823 Remote Similarity NPD6559 Discontinued
0.6791 Remote Similarity NPD8127 Discontinued
0.6788 Remote Similarity NPD7808 Phase 3
0.6788 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6774 Remote Similarity NPD919 Approved
0.6753 Remote Similarity NPD8312 Approved
0.6753 Remote Similarity NPD8313 Approved
0.6742 Remote Similarity NPD7236 Approved
0.6736 Remote Similarity NPD7251 Discontinued
0.6718 Remote Similarity NPD8407 Phase 2
0.6703 Remote Similarity NPD5402 Approved
0.6703 Remote Similarity NPD3817 Phase 2
0.6702 Remote Similarity NPD1247 Approved
0.6702 Remote Similarity NPD7199 Phase 2
0.6702 Remote Similarity NPD3751 Discontinued
0.6685 Remote Similarity NPD6801 Discontinued
0.6684 Remote Similarity NPD6797 Phase 2
0.6683 Remote Similarity NPD7435 Discontinued
0.6667 Remote Similarity NPD3787 Discontinued
0.6667 Remote Similarity NPD5844 Phase 1
0.6649 Remote Similarity NPD8368 Discontinued
0.6648 Remote Similarity NPD7239 Suspended
0.6632 Remote Similarity NPD7074 Phase 3
0.6631 Remote Similarity NPD4381 Clinical (unspecified phase)
0.663 Remote Similarity NPD6273 Approved
0.6615 Remote Similarity NPD3818 Discontinued
0.6615 Remote Similarity NPD7228 Approved
0.6611 Remote Similarity NPD6799 Approved
0.6602 Remote Similarity NPD7698 Approved
0.6602 Remote Similarity NPD7697 Approved
0.6602 Remote Similarity NPD7696 Phase 3
0.6593 Remote Similarity NPD920 Approved
0.6593 Remote Similarity NPD6980 Clinical (unspecified phase)
0.658 Remote Similarity NPD7054 Approved
0.6578 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6578 Remote Similarity NPD4967 Phase 2
0.6578 Remote Similarity NPD4966 Approved
0.6578 Remote Similarity NPD4965 Approved
0.6571 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6571 Remote Similarity NPD7874 Approved
0.6566 Remote Similarity NPD8150 Discontinued
0.6546 Remote Similarity NPD7472 Approved
0.6536 Remote Similarity NPD4628 Phase 3
0.6524 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6514 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6513 Remote Similarity NPD7993 Clinical (unspecified phase)
0.651 Remote Similarity NPD6166 Phase 2
0.651 Remote Similarity NPD6167 Clinical (unspecified phase)
0.651 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6508 Remote Similarity NPD6234 Discontinued
0.6505 Remote Similarity NPD37 Approved
0.6503 Remote Similarity NPD5403 Approved
0.65 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6498 Remote Similarity NPD7907 Approved
0.649 Remote Similarity NPD8320 Phase 1
0.649 Remote Similarity NPD7870 Phase 2
0.649 Remote Similarity NPD7871 Phase 2
0.649 Remote Similarity NPD8319 Approved
0.6489 Remote Similarity NPD3882 Suspended
0.6486 Remote Similarity NPD7028 Phase 2
0.6484 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6484 Remote Similarity NPD642 Clinical (unspecified phase)
0.6484 Remote Similarity NPD5401 Approved
0.648 Remote Similarity NPD7240 Approved
0.6477 Remote Similarity NPD7473 Discontinued
0.6476 Remote Similarity NPD7701 Phase 2
0.6471 Remote Similarity NPD7319 Approved
0.6461 Remote Similarity NPD5763 Approved
0.6461 Remote Similarity NPD5762 Approved
0.6461 Remote Similarity NPD1471 Phase 3
0.6458 Remote Similarity NPD3926 Phase 2
0.6456 Remote Similarity NPD6776 Approved
0.6456 Remote Similarity NPD4107 Approved
0.6456 Remote Similarity NPD6779 Approved
0.6456 Remote Similarity NPD6778 Approved
0.6456 Remote Similarity NPD6781 Approved
0.6456 Remote Similarity NPD6782 Approved
0.6456 Remote Similarity NPD6780 Approved
0.6456 Remote Similarity NPD6777 Approved
0.6455 Remote Similarity NPD3749 Approved
0.6452 Remote Similarity NPD7411 Suspended
0.6432 Remote Similarity NPD7458 Discontinued
0.6418 Remote Similarity NPD8435 Approved
0.641 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6406 Remote Similarity NPD6232 Discontinued
0.6404 Remote Similarity NPD2796 Approved
0.6398 Remote Similarity NPD4380 Phase 2
0.6385 Remote Similarity NPD7801 Approved
0.6385 Remote Similarity NPD7783 Phase 2
0.6385 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6383 Remote Similarity NPD8455 Phase 2
0.6383 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6374 Remote Similarity NPD643 Clinical (unspecified phase)
0.6364 Remote Similarity NPD1933 Approved
0.6359 Remote Similarity NPD7699 Phase 2
0.6359 Remote Similarity NPD7700 Phase 2
0.6354 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6354 Remote Similarity NPD6959 Discontinued
0.6353 Remote Similarity NPD7078 Approved
0.6346 Remote Similarity NPD4482 Phase 3
0.634 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6339 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6337 Remote Similarity NPD8361 Approved
0.6337 Remote Similarity NPD8360 Approved
0.633 Remote Similarity NPD1934 Approved
0.6316 Remote Similarity NPD7736 Approved
0.6316 Remote Similarity NPD7058 Phase 2
0.6316 Remote Similarity NPD7768 Phase 2
0.6316 Remote Similarity NPD7057 Phase 3
0.6307 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6304 Remote Similarity NPD2534 Approved
0.6304 Remote Similarity NPD2533 Approved
0.6304 Remote Similarity NPD2532 Approved
0.6304 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6296 Remote Similarity NPD1465 Phase 2
0.6294 Remote Similarity NPD7507 Approved
0.6291 Remote Similarity NPD8151 Discontinued
0.6278 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6278 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6278 Remote Similarity NPD6004 Phase 3
0.6278 Remote Similarity NPD6002 Phase 3
0.6278 Remote Similarity NPD6005 Phase 3
0.6276 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6273 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6271 Remote Similarity NPD6355 Discontinued
0.6264 Remote Similarity NPD6832 Phase 2
0.6257 Remote Similarity NPD3226 Approved
0.6257 Remote Similarity NPD3748 Approved
0.6256 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6256 Remote Similarity NPD4111 Phase 1
0.6256 Remote Similarity NPD4665 Approved
0.625 Remote Similarity NPD8285 Discontinued
0.625 Remote Similarity NPD8032 Phase 2
0.6235 Remote Similarity NPD7492 Approved
0.6221 Remote Similarity NPD7930 Approved
0.622 Remote Similarity NPD8486 Clinical (unspecified phase)
0.6214 Remote Similarity NPD6534 Approved
0.6214 Remote Similarity NPD6535 Approved
0.6211 Remote Similarity NPD2801 Approved
0.6209 Remote Similarity NPD1243 Approved
0.6201 Remote Similarity NPD7097 Phase 1
0.6199 Remote Similarity NPD6616 Approved
0.619 Remote Similarity NPD6054 Approved
0.6188 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6188 Remote Similarity NPD2346 Discontinued
0.6185 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6183 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6173 Remote Similarity NPD2403 Approved
0.617 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6161 Remote Similarity NPD6823 Phase 2
0.6158 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6154 Remote Similarity NPD1549 Phase 2
0.6141 Remote Similarity NPD3887 Approved
0.6141 Remote Similarity NPD6190 Approved
0.6133 Remote Similarity NPD1551 Phase 2
0.6133 Remote Similarity NPD6100 Approved
0.6133 Remote Similarity NPD6099 Approved
0.6132 Remote Similarity NPD7680 Approved
0.6129 Remote Similarity NPD7410 Clinical (unspecified phase)
0.612 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6118 Remote Similarity NPD6370 Approved
0.6099 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6099 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6094 Remote Similarity NPD5353 Approved
0.6089 Remote Similarity NPD5735 Approved
0.6087 Remote Similarity NPD3750 Approved
0.6085 Remote Similarity NPD3057 Approved
0.6077 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6077 Remote Similarity NPD7033 Discontinued
0.6077 Remote Similarity NPD2799 Discontinued
0.6077 Remote Similarity NPD8485 Approved
0.6075 Remote Similarity NPD7999 Approved
0.6071 Remote Similarity NPD7315 Approved
0.6071 Remote Similarity NPD7229 Phase 3
0.6069 Remote Similarity NPD8293 Discontinued
0.6066 Remote Similarity NPD970 Clinical (unspecified phase)
0.6061 Remote Similarity NPD7048 Phase 3
0.6059 Remote Similarity NPD6015 Approved
0.6059 Remote Similarity NPD6016 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data